DAVID KANAMORI M.D. NPI 1942297361

NPI Information

  • NPI: 1942297361
  • Provider Name: DAVID KANAMORI, M.D.
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6501 TRUXTUN AVE
    BAKERSFIELD, CA
    ZIP 93309
  • Phone: (661) 322-2206

Map and Directions

Get Directions

NPI Details

David Kanamori, M.D. is a specialist in Bakersfield, CA with 34 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. David Kanamori, M.D. NPI is 1942297361. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6501 TRUXTUN AVE
BAKERSFIELD, CA
ZIP 93309-633
Phone: (661) 322-2206
Fax: (661) 327-7027

The NPI 1942297361 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Uric acid level, blood (HCPCS:84550)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Magnesium level (HCPCS:83735)
  • Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Iron level (HCPCS:83540)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroid hormone evaluation (HCPCS:84479)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml (HCPCS:A9579)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Blood test, clotting time (HCPCS:85610)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of chest, 2 views (HCPCS:71046)
  • 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Folic acid level, serum (HCPCS:82746)
  • Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) (HCPCS:G0279)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Complete ultrasound scan of abdomen (HCPCS:76700)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Screening 3d breast mammography (HCPCS:77063)
  • Screening mammography (HCPCS:77067)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Diagnostic mammography of both breasts (HCPCS:77066)
  • Prealbumin (protein) level (HCPCS:84134)
  • Injection, furosemide, up to 20 mg (HCPCS:J1940)
  • Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
  • Diagnostic mammography of 1 breast (HCPCS:77065)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Complete ultrasound scan of 1 breast (HCPCS:76641)
  • Blood creatinine level (HCPCS:82565)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
  • Limited ultrasound scan of abdomen (HCPCS:76705)
  • Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 9/30/2005 and was last updated on 10/5/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistA69648CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100A696480MEDICARE PINCALIFORNIA
2A69648OTHERCALIFORNIALICENSE
3H05257MEDICARE UPINCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.